English
简体中文
Total: £ 56.28
Published Date: 2026-01-30 | Pages: 133 | Tables: 132 | Pharma & Healthcare
The global Cas9 Nuclease market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cas9 Nuclease competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Cas9 nuclease is a RNA-guided enzyme derived from the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) system, specifically associated with bacteria. It functions as a programmable endonuclease that can identify and cleave double-stranded DNA at specific sequences directed by a combination of a guide RNA (gRNA) and a protospacer adjacent motif (PAM) sequence. Cas9 is widely used in genetic engineering and biotechnology for precise gene editing.
The North American market for Cas9 Nuclease is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cas9 Nuclease is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Cas9 Nuclease include Thermo Fisher Scientific, Danaher, Sigma-Aldrich, OriGene Technologies, New England Biolabs, GenScript, Horizon Discovery, Agilent, BPS Bioscience, Nippon Gene, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cas9 Nuclease market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cas9 Nuclease. The Cas9 Nuclease market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cas9 Nuclease market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cas9 Nuclease manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific
Danaher
Sigma-Aldrich
OriGene Technologies
New England Biolabs
GenScript
Horizon Discovery
Agilent
BPS Bioscience
Nippon Gene
Novoprotein
Applied Biological Materials
Stemcell Technologies
Kactus
Abnova
SBS Genetech
Segment by Type
Cas9 Protein
Cas9 mRNA
Cas9 Plasmid
Cas9 Lentivirus
by Application
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Cas9 Nuclease manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Cas9 Nuclease sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Cas9 Nuclease Market Overview
1.1 Product Definition
1.2 Cas9 Nuclease by Type
1.2.1 Global Cas9 Nuclease Market Value by Type: 2025 vs 2032
1.2.2 Cas9 Protein
1.2.3 Cas9 mRNA
1.2.4 Cas9 Plasmid
1.2.5 Cas9 Lentivirus
1.3 Cas9 Nuclease by Application
1.3.1 Global Cas9 Nuclease Market Value by Application: 2025 vs 2032
1.3.2 Gene Editing Cell Line Construction
1.3.3 Animal Models
1.3.4 Bioagriculture
1.3.5 Gene Therapy
1.3.6 Other
1.4 Global Cas9 Nuclease Market Size Estimates and Forecasts
1.4.1 Global Cas9 Nuclease Revenue 2021–2032
1.4.2 Global Cas9 Nuclease Sales 2021–2032
1.4.3 Global Cas9 Nuclease Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Cas9 Nuclease Market Competition by Manufacturers
2.1 Global Cas9 Nuclease Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cas9 Nuclease Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cas9 Nuclease Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cas9 Nuclease, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cas9 Nuclease, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cas9 Nuclease, Product Types and Applications
2.7 Global Key Manufacturers of Cas9 Nuclease, Date of Entry into the Industry
2.8 Global Cas9 Nuclease Market Competitive Situation and Trends
2.8.1 Global Cas9 Nuclease Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cas9 Nuclease Players Market Share by Revenue
2.8.3 Global Cas9 Nuclease Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cas9 Nuclease Market Scenario by Region
3.1 Global Cas9 Nuclease Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cas9 Nuclease Sales by Region: 2021–2032
3.2.1 Global Cas9 Nuclease Sales by Region: 2021–2026
3.2.2 Global Cas9 Nuclease Sales by Region: 2027–2032
3.3 Global Cas9 Nuclease Revenue by Region: 2021–2032
3.3.1 Global Cas9 Nuclease Revenue by Region: 2021–2026
3.3.2 Global Cas9 Nuclease Revenue by Region: 2027–2032
3.4 North America Cas9 Nuclease Market Facts & Figures by Country
3.4.1 North America Cas9 Nuclease Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cas9 Nuclease Sales by Country (2021–2032)
3.4.3 North America Cas9 Nuclease Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cas9 Nuclease Market Facts & Figures by Country
3.5.1 Europe Cas9 Nuclease Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cas9 Nuclease Sales by Country (2021–2032)
3.5.3 Europe Cas9 Nuclease Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cas9 Nuclease Market Facts & Figures by Region
3.6.1 Asia Pacific Cas9 Nuclease Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cas9 Nuclease Sales by Region (2021–2032)
3.6.3 Asia Pacific Cas9 Nuclease Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cas9 Nuclease Market Facts & Figures by Country
3.7.1 Latin America Cas9 Nuclease Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cas9 Nuclease Sales by Country (2021–2032)
3.7.3 Latin America Cas9 Nuclease Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cas9 Nuclease Market Facts & Figures by Country
3.8.1 Middle East and Africa Cas9 Nuclease Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cas9 Nuclease Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cas9 Nuclease Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cas9 Nuclease Sales by Type (2021–2032)
4.1.1 Global Cas9 Nuclease Sales by Type (2021–2026)
4.1.2 Global Cas9 Nuclease Sales by Type (2027–2032)
4.1.3 Global Cas9 Nuclease Sales Market Share by Type (2021–2032)
4.2 Global Cas9 Nuclease Revenue by Type (2021–2032)
4.2.1 Global Cas9 Nuclease Revenue by Type (2021–2026)
4.2.2 Global Cas9 Nuclease Revenue by Type (2027–2032)
4.2.3 Global Cas9 Nuclease Revenue Market Share by Type (2021–2032)
4.3 Global Cas9 Nuclease Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cas9 Nuclease Sales by Application (2021–2032)
5.1.1 Global Cas9 Nuclease Sales by Application (2021–2026)
5.1.2 Global Cas9 Nuclease Sales by Application (2027–2032)
5.1.3 Global Cas9 Nuclease Sales Market Share by Application (2021–2032)
5.2 Global Cas9 Nuclease Revenue by Application (2021–2032)
5.2.1 Global Cas9 Nuclease Revenue by Application (2021–2026)
5.2.2 Global Cas9 Nuclease Revenue by Application (2027–2032)
5.2.3 Global Cas9 Nuclease Revenue Market Share by Application (2021–2032)
5.3 Global Cas9 Nuclease Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Cas9 Nuclease Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Danaher
6.2.1 Danaher Company Information
6.2.2 Danaher Description and Business Overview
6.2.3 Danaher Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Danaher Cas9 Nuclease Product Portfolio
6.2.5 Danaher Recent Developments/Updates
6.3 Sigma-Aldrich
6.3.1 Sigma-Aldrich Company Information
6.3.2 Sigma-Aldrich Description and Business Overview
6.3.3 Sigma-Aldrich Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sigma-Aldrich Cas9 Nuclease Product Portfolio
6.3.5 Sigma-Aldrich Recent Developments/Updates
6.4 OriGene Technologies
6.4.1 OriGene Technologies Company Information
6.4.2 OriGene Technologies Description and Business Overview
6.4.3 OriGene Technologies Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 OriGene Technologies Cas9 Nuclease Product Portfolio
6.4.5 OriGene Technologies Recent Developments/Updates
6.5 New England Biolabs
6.5.1 New England Biolabs Company Information
6.5.2 New England Biolabs Description and Business Overview
6.5.3 New England Biolabs Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 New England Biolabs Cas9 Nuclease Product Portfolio
6.5.5 New England Biolabs Recent Developments/Updates
6.6 GenScript
6.6.1 GenScript Company Information
6.6.2 GenScript Description and Business Overview
6.6.3 GenScript Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 GenScript Cas9 Nuclease Product Portfolio
6.6.5 GenScript Recent Developments/Updates
6.7 Horizon Discovery
6.7.1 Horizon Discovery Company Information
6.7.2 Horizon Discovery Description and Business Overview
6.7.3 Horizon Discovery Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Horizon Discovery Cas9 Nuclease Product Portfolio
6.7.5 Horizon Discovery Recent Developments/Updates
6.8 Agilent
6.8.1 Agilent Company Information
6.8.2 Agilent Description and Business Overview
6.8.3 Agilent Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Agilent Cas9 Nuclease Product Portfolio
6.8.5 Agilent Recent Developments/Updates
6.9 BPS Bioscience
6.9.1 BPS Bioscience Company Information
6.9.2 BPS Bioscience Description and Business Overview
6.9.3 BPS Bioscience Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 BPS Bioscience Cas9 Nuclease Product Portfolio
6.9.5 BPS Bioscience Recent Developments/Updates
6.10 Nippon Gene
6.10.1 Nippon Gene Company Information
6.10.2 Nippon Gene Description and Business Overview
6.10.3 Nippon Gene Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Nippon Gene Cas9 Nuclease Product Portfolio
6.10.5 Nippon Gene Recent Developments/Updates
6.11 Novoprotein
6.11.1 Novoprotein Company Information
6.11.2 Novoprotein Description and Business Overview
6.11.3 Novoprotein Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Novoprotein Cas9 Nuclease Product Portfolio
6.11.5 Novoprotein Recent Developments/Updates
6.12 Applied Biological Materials
6.12.1 Applied Biological Materials Company Information
6.12.2 Applied Biological Materials Description and Business Overview
6.12.3 Applied Biological Materials Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Applied Biological Materials Cas9 Nuclease Product Portfolio
6.12.5 Applied Biological Materials Recent Developments/Updates
6.13 Stemcell Technologies
6.13.1 Stemcell Technologies Company Information
6.13.2 Stemcell Technologies Description and Business Overview
6.13.3 Stemcell Technologies Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Stemcell Technologies Cas9 Nuclease Product Portfolio
6.13.5 Stemcell Technologies Recent Developments/Updates
6.14 Kactus
6.14.1 Kactus Company Information
6.14.2 Kactus Description and Business Overview
6.14.3 Kactus Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Kactus Cas9 Nuclease Product Portfolio
6.14.5 Kactus Recent Developments/Updates
6.15 Abnova
6.15.1 Abnova Company Information
6.15.2 Abnova Description and Business Overview
6.15.3 Abnova Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Abnova Cas9 Nuclease Product Portfolio
6.15.5 Abnova Recent Developments/Updates
6.16 SBS Genetech
6.16.1 SBS Genetech Company Information
6.16.2 SBS Genetech Description and Business Overview
6.16.3 SBS Genetech Cas9 Nuclease Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 SBS Genetech Cas9 Nuclease Product Portfolio
6.16.5 SBS Genetech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cas9 Nuclease Industry Chain Analysis
7.2 Cas9 Nuclease Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cas9 Nuclease Production Mode & Process Analysis
7.4 Cas9 Nuclease Sales and Marketing
7.4.1 Cas9 Nuclease Sales Channels
7.4.2 Cas9 Nuclease Distributors
7.5 Cas9 Nuclease Customer Analysis
8 Cas9 Nuclease Market Dynamics
8.1 Cas9 Nuclease Industry Trends
8.2 Cas9 Nuclease Market Drivers
8.3 Cas9 Nuclease Market Challenges
8.4 Cas9 Nuclease Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Cas9 Nuclease Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Cas9 Nuclease Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Cas9 Nuclease Market Competitive Situation by Manufacturers in 2025
Table 4. Global Cas9 Nuclease Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Cas9 Nuclease Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Cas9 Nuclease Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Cas9 Nuclease Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Cas9 Nuclease Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Cas9 Nuclease, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Cas9 Nuclease, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Cas9 Nuclease, Product Types and Applications
Table 12. Global Key Manufacturers of Cas9 Nuclease, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cas9 Nuclease Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cas9 Nuclease Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cas9 Nuclease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Cas9 Nuclease Sales by Region (K Units), 2021–2026
Table 18. Global Cas9 Nuclease Sales Market Share by Region (2021–2026)
Table 19. Global Cas9 Nuclease Sales by Region (K Units), 2027–2032
Table 20. Global Cas9 Nuclease Sales Market Share by Region (2027–2032)
Table 21. Global Cas9 Nuclease Revenue by Region (US$ Million), 2021–2026
Table 22. Global Cas9 Nuclease Revenue Market Share by Region (2021–2026)
Table 23. Global Cas9 Nuclease Revenue by Region (US$ Million), 2027–2032
Table 24. Global Cas9 Nuclease Revenue Market Share by Region (2027–2032)
Table 25. North America Cas9 Nuclease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Cas9 Nuclease Sales by Country (K Units), 2021–2026
Table 27. North America Cas9 Nuclease Sales by Country (K Units), 2027–2032
Table 28. North America Cas9 Nuclease Revenue by Country (US$ Million), 2021–2026
Table 29. North America Cas9 Nuclease Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Cas9 Nuclease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Cas9 Nuclease Sales by Country (K Units), 2021–2026
Table 32. Europe Cas9 Nuclease Sales by Country (K Units), 2027–2032
Table 33. Europe Cas9 Nuclease Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Cas9 Nuclease Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Cas9 Nuclease Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Cas9 Nuclease Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Cas9 Nuclease Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Cas9 Nuclease Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Cas9 Nuclease Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Cas9 Nuclease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Cas9 Nuclease Sales by Country (K Units), 2021–2026
Table 42. Latin America Cas9 Nuclease Sales by Country (K Units), 2027–2032
Table 43. Latin America Cas9 Nuclease Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Cas9 Nuclease Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Cas9 Nuclease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Cas9 Nuclease Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Cas9 Nuclease Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Cas9 Nuclease Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Cas9 Nuclease Revenue by Country (US$ Million), 2027–2032
Table 50. Global Cas9 Nuclease Sales (K Units) by Type (2021–2026)
Table 51. Global Cas9 Nuclease Sales (K Units) by Type (2027–2032)
Table 52. Global Cas9 Nuclease Sales Market Share by Type (2021–2026)
Table 53. Global Cas9 Nuclease Sales Market Share by Type (2027–2032)
Table 54. Global Cas9 Nuclease Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Cas9 Nuclease Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Cas9 Nuclease Revenue Market Share by Type (2021–2026)
Table 57. Global Cas9 Nuclease Revenue Market Share by Type (2027–2032)
Table 58. Global Cas9 Nuclease Price (US$/Unit) by Type (2021–2026)
Table 59. Global Cas9 Nuclease Price (US$/Unit) by Type (2027–2032)
Table 60. Global Cas9 Nuclease Sales (K Units) by Application (2021–2026)
Table 61. Global Cas9 Nuclease Sales (K Units) by Application (2027–2032)
Table 62. Global Cas9 Nuclease Sales Market Share by Application (2021–2026)
Table 63. Global Cas9 Nuclease Sales Market Share by Application (2027–2032)
Table 64. Global Cas9 Nuclease Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Cas9 Nuclease Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Cas9 Nuclease Revenue Market Share by Application (2021–2026)
Table 67. Global Cas9 Nuclease Revenue Market Share by Application (2027–2032)
Table 68. Global Cas9 Nuclease Price (US$/Unit) by Application (2021–2026)
Table 69. Global Cas9 Nuclease Price (US$/Unit) by Application (2027–2032)
Table 70. Thermo Fisher Scientific Company Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Thermo Fisher Scientific Cas9 Nuclease Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. Danaher Company Information
Table 76. Danaher Description and Business Overview
Table 77. Danaher Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Danaher Cas9 Nuclease Product
Table 79. Danaher Recent Developments/Updates
Table 80. Sigma-Aldrich Company Information
Table 81. Sigma-Aldrich Description and Business Overview
Table 82. Sigma-Aldrich Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Sigma-Aldrich Cas9 Nuclease Product
Table 84. Sigma-Aldrich Recent Developments/Updates
Table 85. OriGene Technologies Company Information
Table 86. OriGene Technologies Description and Business Overview
Table 87. OriGene Technologies Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. OriGene Technologies Cas9 Nuclease Product
Table 89. OriGene Technologies Recent Developments/Updates
Table 90. New England Biolabs Company Information
Table 91. New England Biolabs Description and Business Overview
Table 92. New England Biolabs Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. New England Biolabs Cas9 Nuclease Product
Table 94. New England Biolabs Recent Developments/Updates
Table 95. GenScript Company Information
Table 96. GenScript Description and Business Overview
Table 97. GenScript Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. GenScript Cas9 Nuclease Product
Table 99. GenScript Recent Developments/Updates
Table 100. Horizon Discovery Company Information
Table 101. Horizon Discovery Description and Business Overview
Table 102. Horizon Discovery Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Horizon Discovery Cas9 Nuclease Product
Table 104. Horizon Discovery Recent Developments/Updates
Table 105. Agilent Company Information
Table 106. Agilent Description and Business Overview
Table 107. Agilent Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Agilent Cas9 Nuclease Product
Table 109. Agilent Recent Developments/Updates
Table 110. BPS Bioscience Company Information
Table 111. BPS Bioscience Description and Business Overview
Table 112. BPS Bioscience Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. BPS Bioscience Cas9 Nuclease Product
Table 114. BPS Bioscience Recent Developments/Updates
Table 115. Nippon Gene Company Information
Table 116. Nippon Gene Description and Business Overview
Table 117. Nippon Gene Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Nippon Gene Cas9 Nuclease Product
Table 119. Nippon Gene Recent Developments/Updates
Table 120. Novoprotein Company Information
Table 121. Novoprotein Description and Business Overview
Table 122. Novoprotein Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Novoprotein Cas9 Nuclease Product
Table 124. Novoprotein Recent Developments/Updates
Table 125. Applied Biological Materials Company Information
Table 126. Applied Biological Materials Description and Business Overview
Table 127. Applied Biological Materials Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Applied Biological Materials Cas9 Nuclease Product
Table 129. Applied Biological Materials Recent Developments/Updates
Table 130. Stemcell Technologies Company Information
Table 131. Stemcell Technologies Description and Business Overview
Table 132. Stemcell Technologies Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Stemcell Technologies Cas9 Nuclease Product
Table 134. Stemcell Technologies Recent Developments/Updates
Table 135. Kactus Company Information
Table 136. Kactus Description and Business Overview
Table 137. Kactus Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Kactus Cas9 Nuclease Product
Table 139. Kactus Recent Developments/Updates
Table 140. Abnova Company Information
Table 141. Abnova Description and Business Overview
Table 142. Abnova Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Abnova Cas9 Nuclease Product
Table 144. Abnova Recent Developments/Updates
Table 145. SBS Genetech Company Information
Table 146. SBS Genetech Description and Business Overview
Table 147. SBS Genetech Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. SBS Genetech Cas9 Nuclease Product
Table 149. SBS Genetech Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Cas9 Nuclease Distributors List
Table 153. Cas9 Nuclease Customers List
Table 154. Cas9 Nuclease Market Trends
Table 155. Cas9 Nuclease Market Drivers
Table 156. Cas9 Nuclease Market Challenges
Table 157. Cas9 Nuclease Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cas9 Nuclease
Figure 2. Global Cas9 Nuclease Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Cas9 Nuclease Market Share by Type: 2025 & 2032
Figure 4. Cas9 Protein Product Picture
Figure 5. Cas9 mRNA Product Picture
Figure 6. Cas9 Plasmid Product Picture
Figure 7. Cas9 Lentivirus Product Picture
Figure 8. Global Cas9 Nuclease Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Cas9 Nuclease Market Share by Application: 2025 & 2032
Figure 10. Gene Editing Cell Line Construction
Figure 11. Animal Models
Figure 12. Bioagriculture
Figure 13. Gene Therapy
Figure 14. Other
Figure 15. Global Cas9 Nuclease Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Cas9 Nuclease Market Size (US$ Million), 2021–2032
Figure 17. Global Cas9 Nuclease Sales (K Units), 2021–2032
Figure 18. Global Cas9 Nuclease Average Price (US$/Unit), 2021–2032
Figure 19. Cas9 Nuclease Report Years Considered
Figure 20. Cas9 Nuclease Sales Share by Manufacturers in 2025
Figure 21. Global Cas9 Nuclease Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Cas9 Nuclease Players: Market Share by Revenue in Cas9 Nuclease in 2025
Figure 23. Cas9 Nuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Cas9 Nuclease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Cas9 Nuclease Sales Market Share by Country (2021–2032)
Figure 26. North America Cas9 Nuclease Revenue Market Share by Country (2021–2032)
Figure 27. United States Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Cas9 Nuclease Sales Market Share by Country (2021–2032)
Figure 30. Europe Cas9 Nuclease Revenue Market Share by Country (2021–2032)
Figure 31. Germany Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Cas9 Nuclease Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Cas9 Nuclease Revenue Market Share by Region (2021–2032)
Figure 38. China Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Cas9 Nuclease Sales Market Share by Country (2021–2032)
Figure 46. Latin America Cas9 Nuclease Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Cas9 Nuclease Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Cas9 Nuclease Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Cas9 Nuclease Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Cas9 Nuclease by Type (2021–2032)
Figure 57. Global Revenue Market Share of Cas9 Nuclease by Type (2021–2032)
Figure 58. Global Cas9 Nuclease Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Cas9 Nuclease by Application (2021–2032)
Figure 60. Global Revenue Market Share of Cas9 Nuclease by Application (2021–2032)
Figure 61. Global Cas9 Nuclease Price (US$/Unit) by Application (2021–2032)
Figure 62. Cas9 Nuclease Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
